Cellvanta is a boutique life sciences advisory company supporting biotech organisations, technology developers and ecosystem partners across cell therapy development. We provide specialist technical and strategic expertise to address complex analytical, CMC and product development challenges and support informed development, investment and partnership decisions. With deep expertise in cell therapy and analytical development, Cellvanta provides advisory support across potency and functional assay strategy, product characterisation, critical quality attribute identification, comparability, analytical gap assessment, assay qualification and technology transfer. Our expertise includes advanced flow cytometry and cell-based assay development, alongside broader analytical development and CMC strategy. Cellvanta also provides independent technical due diligence, helping investors, developers and partners assess scientific evidence, development strategy, technical risk and the maturity of emerging technologies and therapeutic programmes. Cellvanta is led by Siddharth Krishnan, PhD, drawing on hands-on advanced therapy development experience across industry and translational environments.